901 related articles for article (PubMed ID: 9811741)
1. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
McChesney MB; Collins JR; Lu D; Lu X; Torten J; Ashley RL; Cloyd MW; Miller CJ
J Virol; 1998 Dec; 72(12):10029-35. PubMed ID: 9811741
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.
Buge SL; Murty L; Arora K; Kalyanaraman VS; Markham PD; Richardson ES; Aldrich K; Patterson LJ; Miller CJ; Cheng SM; Robert-Guroff M
J Virol; 1999 Sep; 73(9):7430-40. PubMed ID: 10438833
[TBL] [Abstract][Full Text] [Related]
3. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.
Miller CJ; McChesney MB; Lü X; Dailey PJ; Chutkowski C; Lu D; Brosio P; Roberts B; Lu Y
J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322
[TBL] [Abstract][Full Text] [Related]
4. A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations.
Ma ZM; Abel K; Rourke T; Wang Y; Miller CJ
J Virol; 2004 Dec; 78(24):14048-52. PubMed ID: 15564513
[TBL] [Abstract][Full Text] [Related]
5. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
[TBL] [Abstract][Full Text] [Related]
6. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.
Miller CJ; Marthas M; Greenier J; Lu D; Dailey PJ; Lu Y
J Virol; 1998 Apr; 72(4):3248-58. PubMed ID: 9525652
[TBL] [Abstract][Full Text] [Related]
7. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia.
Miller CJ; Marthas M; Torten J; Alexander NJ; Moore JP; Doncel GF; Hendrickx AG
J Virol; 1994 Oct; 68(10):6391-400. PubMed ID: 8083977
[TBL] [Abstract][Full Text] [Related]
8. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ
AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249
[TBL] [Abstract][Full Text] [Related]
9. Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.
Tasca S; Tsai L; Trunova N; Gettie A; Saifuddin M; Bohm R; Chakrabarti L; Cheng-Mayer C
Virology; 2007 Oct; 367(1):196-211. PubMed ID: 17574643
[TBL] [Abstract][Full Text] [Related]
10. Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.
Gordon SN; Doster MN; Kines RC; Keele BF; Brocca-Cofano E; Guan Y; Pegu P; Liyanage NP; Vaccari M; Cuburu N; Buck CB; Ferrari G; Montefiori D; Piatak M; Lifson JD; Xenophontos AM; Venzon D; Robert-Guroff M; Graham BS; Lowy DR; Schiller JT; Franchini G
J Immunol; 2014 Dec; 193(12):6172-83. PubMed ID: 25398324
[TBL] [Abstract][Full Text] [Related]
11. Variation in virological parameters and antibody responses in macaques after atraumatic vaginal exposure to a pathogenic primary isolate of SIVmac251.
Neildez O; Le Grand R; Chéret A; Caufour P; Vaslin B; Matheux F; Théodoro F; Roques P; Dormont D
Res Virol; 1998; 149(1):53-68. PubMed ID: 9561564
[TBL] [Abstract][Full Text] [Related]
12. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
[TBL] [Abstract][Full Text] [Related]
13. Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251.
Stevceva L; Kelsall B; Nacsa J; Moniuszko M; Hel Z; Tryniszewska E; Franchini G
J Virol; 2002 Jan; 76(1):9-18. PubMed ID: 11739667
[TBL] [Abstract][Full Text] [Related]
14. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
[TBL] [Abstract][Full Text] [Related]
15. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
[TBL] [Abstract][Full Text] [Related]
16. Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency virus.
von Gegerfelt A; Valentin A; Alicea C; Van Rompay KK; Marthas ML; Montefiori DC; Pavlakis GN; Felber BK
J Immunol; 2010 Sep; 185(6):3348-58. PubMed ID: 20702730
[TBL] [Abstract][Full Text] [Related]
17. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.
Helmold Hait S; Vargas-Inchaustegui DA; Musich T; Mohanram V; Tuero I; Venzon DJ; Bear J; Rosati M; Vaccari M; Franchini G; Felber BK; Pavlakis GN; Robert-Guroff M
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463978
[TBL] [Abstract][Full Text] [Related]
18. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.
Greenier JL; Miller CJ; Lu D; Dailey PJ; Lü FX; Kunstman KJ; Wolinsky SM; Marthas ML
J Virol; 2001 Apr; 75(8):3753-65. PubMed ID: 11264364
[TBL] [Abstract][Full Text] [Related]
19. Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.
Breed MW; Elser SE; Torben W; Jordan AP; Aye PP; Midkiff C; Schiro F; Sugimoto C; Alvarez-Hernandez X; Blair RV; Somasunderam A; Utay NS; Kuroda MJ; Pahar B; Wiseman RW; O'Connor DH; LaBranche CC; Montefiori DC; Marsh M; Li Y; Piatak M; Lifson JD; Keele BF; Fultz PN; Lackner AA; Hoxie JA
J Virol; 2015 Oct; 89(20):10156-75. PubMed ID: 26223646
[TBL] [Abstract][Full Text] [Related]
20. Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS.
Joag SV; Adany I; Li Z; Foresman L; Pinson DM; Wang C; Stephens EB; Raghavan R; Narayan O
J Virol; 1997 May; 71(5):4016-23. PubMed ID: 9094679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
